Results 11 to 20 of about 6,917 (184)

Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study. [PDF]

open access: yesJ Surg Oncol
ABSTRACT Background and Objective Stage IVB high‐grade serous ovarian cancer (HGSOC) carries a poor prognosis. We aimed to: (1) describe the characteristics and survival of patients treated with primary cytoreductive surgery (PCS), interval cytoreductive surgery (ICS) or chemotherapy alone, (2) investigate the correlation between disease distribution ...
Benseler A   +6 more
europepmc   +2 more sources

Robotic-Assisted Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy in Metastatic Pleuropulmonary Leiomyosarcoma: A Case Report. [PDF]

open access: yesCase Rep Oncol Med
Leiomyosarcoma (LMS) is a rare and aggressive soft tissue sarcoma known for its propensity for hematogenous dissemination, frequently involving the lungs and pleura. We present a case of metastatic pleuropulmonary LMS managed with a novel combined approach: robotic‐assisted cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC).
de Oliveira MC   +5 more
europepmc   +2 more sources

A 61-year-old woman with jejunal lymphatic malformation visualized on computed tomography: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Jejunal lymphatic malformations are congenital lesions that are seldom diagnosed in adults and rarely seen on imaging. Case presentation A 61-year-old Caucasian woman was initially diagnosed and treated for mucinous ovarian carcinoma. After an
Mark Rupasinghe   +6 more
doaj   +1 more source

Surgical treatment for high-grade pseudomyxoma peritonei originated from appendix: Analysis of clinical outcomes of repeated debulking surgery [PDF]

open access: yesKorean Journal of Clinical Oncology, 2016
Purpose To evaluate the effect of repeated debulking surgery for high-grade pseudomyxoma peritonei (PMP) originating from the appendix. Methods Between January 1998 and December 2014, fifty patients, who underwent debulking surgery for high-grade PMP ...
Jung Hyun Park   +9 more
doaj   +1 more source

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures [PDF]

open access: yesJAMA Network Open, 2019
Currently, rates of referral of patients with peritoneal metastasis in the United States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are low, in part because of the misperception of high morbidity and mortality rates.
Foster, Jason M.   +7 more
openaire   +2 more sources

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

open access: yes, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim   +3 more
core   +4 more sources

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

open access: yesWorld Journal of Surgical Oncology, 2020
Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Juan José Segura-Sampedro   +3 more
doaj   +1 more source

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2022
Objective: to evaluate the quality of surgical treatment of ovarian cancer patients and assess the impact of adequate surgical oncological treatment on disease-free survival and overall survival of patients with advanced epithelial ovarian cancer ...
FLAVIO HENRIQUE FARIA   +3 more
doaj   +2 more sources

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2023
Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients ...
JAIRO SEBASTIÁN ASTUDILLO VALLEJO   +7 more
doaj   +2 more sources

Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Peritoneal carcinomatosis (PC) can arise directly from peritoneum (primary) or from regional spread of gastrointestinal and gynecological malignancies. It is often considered a terminal event.
Naveen Padmanabhan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy